PIK3CA and breast cancer: The median age at BC diagnosis was higher in PIK3CA-mutated cases (53.0 vs. 50.0 years, p = 0.0002); PIK3CA variants were detected in 43.9% of patients older than 60 years compared to 33.9% in younger individuals (p = 0.0002).